Antifungal agents, WO2009025733

Bibliography

• Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511
   PubMed Web of Science ®Google Scholar
• Larocco MT, Burgert SJ. Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 1997;10:277-97
   PubMed Web of Science ®Google Scholar
• Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997;10:86-124
   PubMed Web of Science ®Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54
   PubMed Web of Science ®Google Scholar
• Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) Isolates in New York City. J Clin Microbiol 2000;38:1974-6
   PubMed Web of Science ®Google Scholar
• Vicente MF, Basilio A, Cabello A, Pelaez F. Microbial natural products as a source of antifungals. Clin Microbiol Infect 2003;9:15-32
   PubMed Web of Science ®Google Scholar
• Chakrabarti A. Microbiology of systemic fungal infections. J Postgrad Med 2005;51:16-20
   Google Scholar
• Lemke A, Kiderlen AF, Kayser O. Amphotericin B. Appl Microbiol Biotechnol 2005;68:151-62
   PubMed Web of Science ®Google Scholar
• Arikan S, Rex JH. Nystatin LF Aronex/Abbott. Curr Opin Invest Drugs 2001;2:488-95
   PubMedGoogle Scholar
• Majoros L, Kardos G. Fungicidal activity of azole antifungal agents. Anti Infect Agents Med Chem 2008;7:118-25
   Google Scholar
• Birnbaum JE. Pharmacology of the allylamines. J Am Acad Dermatol 1990;23:782-5
   PubMed Web of Science ®Google Scholar
• Fromtling RA. Terbinafine (Lamisil). Drugs Today 1992;28:501-8
   Google Scholar
• Fromtling RA. Amorolfine (Loceryl). Drugs Today 1992;28:399-403
   Google Scholar
• McCormack PL, Perry CM. Caspofungin: a review of its use in the treatment of fungal infections. Drugs 2005;65:2049-68
   PubMed Web of Science ®Google Scholar
• Turner MS, Drew RH, Perfect JR. Emerging echinocandins for treatment of invasive fungal infections. Expert Opin Emerg Drugs 2006;11:231-50
   PubMedGoogle Scholar
• Renslo AR. The echinocandins: total and semi-synthetic approaches in antifungal drug discovery. Anti Infect Agents Med Chem 2007;6:201-12
   Google Scholar
• Leonard WR Jr, Belyk KM, Conlon DA, Synthesis of the antifungal beta-1,3-glucan synthase inhibitor CANCIDAS (caspofungin acetate) from pneumocandin B. J Organic Chem 2007;72:2335-43
   PubMed Web of Science ®Google Scholar
• Zaas AK. Echinocandins: a wealth of choice–How clinically different are they? Curr Opin Infect Dis 2008;21:426-32
   PubMed Web of Science ®Google Scholar
• Ru¨ping MJ, Vehreschild JJ, Farowski F, . Anidulafungin: advantage for the newcomer? Expert Rev Clin Pharmacol 2008;1:207-16
   PubMedGoogle Scholar
• Fritz JM, Brielmaier BD, Dubberke ER. Micafungin for the prophylaxis and treatment of Candida infections. Expert Rev Anti Infect Ther 2008;6:153-62
   PubMed Web of Science ®Google Scholar
• Niimi K, Niimi M. The mechanisms of resistance to echinocandin class of antifungal drugs. Jpn J Med Mycol 2009;50:57-66
   Google Scholar
• Zhang D, Miller MJ. Polyoxins and nikkomycins: progress in synthetic and biological studies. Curr Pharm Des 1999;5:73-99
   PubMed Web of Science ®Google Scholar
• Vicente F, Basilio A, Platas G, Distribution of the antifungal agents sordarins across filamentous fungi. Mycol Res 2009;113:754-70
   PubMed Web of Science ®Google Scholar
• Sakiyan I, Log˘og˘lu E, Arslan S, Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid (glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese (III) complexes. BioMetals 2004;17:115-20
   PubMed Web of Science ®Google Scholar
• Chohan ZH, Arif M, Akhtar MA, Metal-based antibacterial and antifungal agents: Synthesis, characterization, and in vitro biological evaluation of Co(II), Cu(II), Ni(II), and Zn(II) complexes with amino acid-derived compounds. Bioinorganic Chem Appl 2006; art. no. 83131
   PubMed Web of Science ®Google Scholar
• Belaid S, Landreau A, Djebbar S, Synthesis, characterization and antifungal activity of a series of manganese(II) and copper(II) complexes with ligands derived from reduced N,N′-O-phenylenebis(salicylideneimine). J Inorg Biochem 2008;102:63-9
   PubMed Web of Science ®Google Scholar
• Di Santo R. Recent patents in antifungal agent discovery. Expert Opin 2008;18:275-92
   Google Scholar
• Lo´ra´nd T, Kocsis B. Recent advances in antifungal agents. Mini Rev Med Chem 2007;7:900-11
   PubMed Web of Science ®Google Scholar
• Ting PC, Walker SS. New agents to treat life-threatening fungal infections. Curr Topics Med Chem 2008;8:592-602
   PubMed Web of Science ®Google Scholar
• Mathew BP, Nath M. Recent approaches to antifungal therapy for invasive mycoses. Chem Med Chem 2009;4:310-23
   Web of Science ®Google Scholar
• Gallagher JC, MacDougall C, Dodds Ashley ES, Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Rev Anti Infect Ther 2004;2:253-68
   PubMedGoogle Scholar
• Shetty A, Barnes RA. New developments in antifungal strategy. Expert Rev Anti Infect Ther 2004;2:269-77
   PubMedGoogle Scholar
• Petrikkos G, Skiada A. Recent advances in antifungal chemotherapy. Int J Antimicrob Agents 2007;30:108-17
   PubMed Web of Science ®Google Scholar
• Sundriyal S, Sharma RK, Jain R. Current advances in antifungal targets and drug development. Curr Med Chem 2006;13:1321-35
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). Rev Iberoam Micol 2009;26:15-22
   PubMed Web of Science ®Google Scholar
• Kim BS, Hwang BK. Microbial fungicides in the control of plant diseases. J Phytopathol 2007;155:641-53
   Web of Science ®Google Scholar
• Huang W, Zhao P-L, Liu C-L, Design, synthesis, and fungicidal activities of new strobilurin derivatives. J Agric Food Chem 2007;55:3004-10
   PubMed Web of Science ®Google Scholar
• Thornton SJ, Wasan KM. The reformulation of Amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis. Expert Opin Drug Deliv 2009;6:271-84
   PubMed Web of Science ®Google Scholar
• Silver L, Bostian K. Screening of natural products for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1990;9:455-61
   PubMed Web of Science ®Google Scholar
• Windsor JB, Roux SJ, Lloyd AM, Thomas CE. Methods and compositions for increasing the efficacy of biologically-active ingredients. US0276339; 2006
   Google Scholar
• Jira V, Jirathitikal V. Anti-fungal composition. US039667; 2003
   Google Scholar
• Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005;4:206-20
   PubMed Web of Science ®Google Scholar
• Franck B. The biosynthesis of the ergochromes. In: PS Steyn, editor, The biosynthesis of mycotoxins: a study in secondary metabolism Academic Press, New York; 1980. p. 157-91
   Google Scholar
• Eglinton G, King FE, Lloyd G, The chemistry of fungi. Part XXXV. A preliminary investigation of ergoflavin. J Chem Soc 1958;1833-42
   Web of Science ®Google Scholar
• Mitsuru S, Chisei S, Kunihiko I. Novel secalonic acid derivatives and method for preparing thereof. EP64199; 1982
   Google Scholar
• Elsässer B, Krohn K, Flörke U, X-ray structure determination, absolute configuration and biological activity of Phomoxanthone A. Eur J Org Chem 2005;4563-70
   Web of Science ®Google Scholar
• Isaka M, Jaturapat A, Rukseree K, Phomoxanthones A and B, novel xanthone dimers from the endophytic fungus phomopsis species. J Nat Prod 2001;64:1015-18
   PubMed Web of Science ®Google Scholar
• Proksa B, Uhrín D, Liptaj T, Šturdíková M. Neosartorin, an ergochrome biosynthesized by Neosartorya fischeri. Phytochemistry 1998;48:1161-4
   Web of Science ®Google Scholar
• Kurobane I, Vining LC, McInnes AG. A new secalonic acid. Linkage between tetrahydroxanthone units determined from deuterium isotope 13C chemical shifts. Tetrahedron Lett 1978;19:4633-6
   Google Scholar
• Yang D-M, Takeda N, Iitaka Y, The structures of eumitrins A1, A2 and B: the yellow pigments of the lichen, Usnea bayleyi(Stirt.)Zahlbr. Tetrahedron 1973;29:519-28
   Web of Science ®Google Scholar
• Hopper JW, Marlow W, Whalley WB, The chemistry of fungi. Part LXV. The structures of ergochrysin A, isoergochrysin A, and ergoxanthin, and of secalonic acids A, B, C, and D. J Chem Soc C 1971;3580-90
   Google Scholar
• Hopper JW, Marlow W, Whalley WB, The position of the biphenyl linkage in the ergot pigments. A partial synthesis of ergoflavin. J Chem Soc D Chem Commun 1971;111-12
   Google Scholar
• Aberhart DJ, DeMayo P. Mould metabolites-V: the constitution of ergoxanthin. Tetrahedron 1966;22:2359-66
   Web of Science ®Google Scholar
• Aberhart DJ, Chen YS, DeMayo P, Stothers JB. Mould metabolites-IV: the isolation and constitution of some ergot pigments. Tetrahedron 1965;21:1417-32
   Web of Science ®Google Scholar
• Zhang W, Krohn K, Flörke U, New mono- and dimeric members of the secalonic acid family: blennolides A-G isolated from the fungus blennoria sp. Chem Eur J 2008;14:4913-23
   PubMed Web of Science ®Google Scholar
• Jiang B, Xu DM, Allocco J, PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol 2008;15:363-74
   PubMedGoogle Scholar
• Haselbeck R, Wall D, Jiang B, Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. Curr Pharm Design 2002;8:1155-72
   PubMed Web of Science ®Google Scholar
• Roemer T, Jiang B, Davison J, Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 2003;50:167-81
   PubMed Web of Science ®Google Scholar
• Xu D, Jiang B, Ketela T, Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathogens 2007;3:0835-848
   Web of Science ®Google Scholar
• Adam GC, Parish CA, Wisniewski D, Application of affinity selection/mass spectrometry to determine the structural isomer of parnafungins responsible for binding polyadenosine polymerase. J Am Chem Soc 2008;130:16704-10
   PubMed Web of Science ®Google Scholar
• Parish CA, Smith SK, Calati K, Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. J Am Chem Soc 2008;130:7060-6
   PubMed Web of Science ®Google Scholar